These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 26067173)

  • 21. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiosynthesis and in Vivo Evaluation of [
    Prabhakaran J; Zanderigo F; Sai KKS; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Mintz A; Mann JJ; Kumar JSD
    ACS Chem Neurosci; 2017 Aug; 8(8):1697-1703. PubMed ID: 28485573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
    Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
    Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 2-{3-[4-(Alkylsulfinyl)phenyl]-1-benzofuran-5-yl}-5-methyl-1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3beta with good brain permeability.
    Saitoh M; Kunitomo J; Kimura E; Iwashita H; Uno Y; Onishi T; Uchiyama N; Kawamoto T; Tanaka T; Mol CD; Dougan DR; Textor GP; Snell GP; Takizawa M; Itoh F; Kori M
    J Med Chem; 2009 Oct; 52(20):6270-86. PubMed ID: 19775160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
    Ye Q; Xu G; Lv D; Cheng Z; Li J; Hu Y
    Bioorg Med Chem; 2009 Jul; 17(13):4302-12. PubMed ID: 19481464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and biological evaluation of novel 7-azaindolyl-heteroaryl-maleimides as potent and selective glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
    O'Neill DJ; Shen L; Prouty C; Conway BR; Westover L; Xu JZ; Zhang HC; Maryanoff BE; Murray WV; Demarest KT; Kuo GH
    Bioorg Med Chem; 2004 Jun; 12(12):3167-85. PubMed ID: 15158785
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New insights concerning insulin synthesis and its secretion in rat hippocampus and cerebral cortex: amyloid-β1-42-induced reduction of proinsulin level via glycogen synthase kinase-3β.
    Nemoto T; Toyoshima-Aoyama F; Yanagita T; Maruta T; Fujita H; Koshida T; Yonaha T; Wada A; Sawaguchi A; Murakami M
    Cell Signal; 2014 Feb; 26(2):253-9. PubMed ID: 24269535
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of [
    Hu K; Patnaik D; Collier TL; Lee KN; Gao H; Swoyer MR; Rotstein BH; Krishnan HS; Liang SH; Wang J; Yan Z; Hooker JM; Vasdev N; Haggarty SJ; Ngai MY
    ACS Med Chem Lett; 2017 Mar; 8(3):287-292. PubMed ID: 28337318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of glycogen synthase kinase-3beta in schizophrenia.
    Koros E; Dorner-Ciossek C
    Drug News Perspect; 2007 Sep; 20(7):437-45. PubMed ID: 17992266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lithium blocks stress-induced changes in depressive-like behavior and hippocampal cell fate: the role of glycogen-synthase-kinase-3beta.
    Silva R; Mesquita AR; Bessa J; Sousa JC; Sotiropoulos I; Leão P; Almeida OF; Sousa N
    Neuroscience; 2008 Mar; 152(3):656-69. PubMed ID: 18291594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and biological evaluation of 3-([1,2,4]triazolo[4,3-a]pyridin-3-yl)-4-(indol-3-yl)-maleimides as potent, selective GSK-3β inhibitors and neuroprotective agents.
    Ye Q; Mao W; Zhou Y; Xu L; Li Q; Gao Y; Wang J; Li C; Xu Y; Xu Y; Liao H; Zhang L; Gao J; Li J; Pang T
    Bioorg Med Chem; 2015 Mar; 23(5):1179-88. PubMed ID: 25662701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and discovery of macrocyclic polyoxygenated bis-7-azaindolylmaleimides as a novel series of potent and highly selective glycogen synthase kinase-3beta inhibitors.
    Kuo GH; Prouty C; DeAngelis A; Shen L; O'Neill DJ; Shah C; Connolly PJ; Murray WV; Conway BR; Cheung P; Westover L; Xu JZ; Look RA; Demarest KT; Emanuel S; Middleton SA; Jolliffe L; Beavers MP; Chen X
    J Med Chem; 2003 Sep; 46(19):4021-31. PubMed ID: 12954055
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
    Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based design of benzo[e]isoindole-1,3-dione derivatives as selective GSK-3β inhibitors to activate Wnt/β-catenin pathway.
    Yue H; Lu F; Shen C; Quan JM
    Bioorg Chem; 2015 Aug; 61():21-7. PubMed ID: 26057861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment with the glycogen synthase kinase-3beta inhibitor, TDZD-8, affects transient cerebral ischemia/reperfusion injury in the rat hippocampus.
    Collino M; Thiemermann C; Mastrocola R; Gallicchio M; Benetti E; Miglio G; Castiglia S; Danni O; Murch O; Dianzani C; Aragno M; Fantozzi R
    Shock; 2008 Sep; 30(3):299-307. PubMed ID: 18323734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A longitudinal FDG-PET study of transgenic mice overexpressing GSK- 3β in the brain.
    de Cristóbal J; Garcia-Garcia L; Delgado M; Pozo MA; Medina M
    Curr Alzheimer Res; 2014 Feb; 11(2):175-81. PubMed ID: 23905999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and preliminary evaluation of novel PET probes for GSK-3 imaging.
    Gundam SR; Bansal A; Kethamreddy M; Ghatamaneni S; Lowe VJ; Murray ME; Pandey MK
    Sci Rep; 2024 Jul; 14(1):15960. PubMed ID: 38987294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of glycogen synthase kinase-3beta protects against kainic acid-induced neurotoxicity in vivo.
    Goodenough S; Conrad S; Skutella T; Behl C
    Brain Res; 2004 Nov; 1026(1):116-25. PubMed ID: 15476703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
    Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
    Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.